Cyclic progesterone and spironolactone treatment for androgenic polycystic ovary syndrome

Prior JC, Kalidasan D, Prior JC, Kalidasan D

doi:10.1186/isrctn99343883

Cyclic progesterone and spironolactone treatment for androgenic polycystic ovary syndrome

Prior JC et al., 2021

DOI 10.1186/isrctn99343883

Abstract

No abstract available for this article.

Topics

PCOS > Treatment > Pharmacological RRM Methods > NaProTECHNOLOGY > Protocol Reproductive Endocrinology > Progesterone > Supplementation

cyclic progesterone pcos treatment, spironolactone androgenic pcos, progesterone therapy polycystic ovary syndrome, cycle-timed progesterone pcos, pcos progesterone protocol, androgen excess pcos treatment, cyclic hormone therapy pcos, progesterone spironolactone combination pcos, pcos root cause treatment, luteal phase progesterone pcos, hormonal treatment polycystic ovary

Cite this article

Prior JC, Kalidasan D (2021). Cyclic progesterone and spironolactone treatment for androgenic polycystic ovary syndrome. *http://isrctn.com/*. https://doi.org/10.1186/isrctn99343883

Cyclic progesterone and spironolactone treatment for androgenic polycystic ovary syndrome

Abstract

Topics

Cite this article

Related articles

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature

"Phase II 6-month Cyclic Progesterone/Spironolactone pilot Therapy Trial in Polycystic Ovary Syndrome : pre-post, single-arm feasibility study"

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes

"SUN-109 Feasibility of Cyclic Progesterone and Spironolactone for PCOS-specific Health-Related Quality of Life—a six-month, Phase II, single arm, single center, open-label study"